Comparison of Nafamostat and Unfractionated Heparin in RRT for Sepsis Associated AKI

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Sepsis
Interventions
DRUG

Nafamostat Mesylate

During RRT, a priming dose of 20 mg of nafamostat mesylate (NM) is administered before initiation of the procedure. Upon starting the machine, there is no loading dose, but a maintenance infusion rate of 25 mg/h of NM is maintained. NM is discontinued in the last half hour before the end of the RRT session.

DRUG

Unfractionated Heparin

During RRT, a priming dose of 50 mg of unfractionated heparin (UFH) is administered before initiation of the procedure. Upon starting the machine, a loading dose of 0.2 mg/kg of UFH is given, followed by a maintenance infusion rate of 0.1 mg/kg/h of UFH. The anticoagulant is discontinued in the last half hour before the end of the RRT session.

Trial Locations (1)

Unknown

Huashan Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Shen Lei

OTHER

NCT06375616 - Comparison of Nafamostat and Unfractionated Heparin in RRT for Sepsis Associated AKI | Biotech Hunter | Biotech Hunter